You are here

Therapeutic Advances in Neurological Disorders

Therapeutic Advances in Neurological Disorders


eISSN: 17562864 | ISSN: 17562864 | Current volume: 16 | Current issue: 1 Frequency: Yearly
Journal Highlights
  • Launched in 2008.
  • Gold open access journal – all articles are made freely available online immediately upon publication.
  • Rigorous peer review.
  • Listed in PubMed Central and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus.
  • A leading gold open access in clinical neurology.
  • Over 400k full-text article views annually.
Therapeutic Advances in Neurological Disorders (TAND) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of neurology. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

This journal flipped to open access on September 1, 2016.

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Neurological Disorders promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the neurology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tand.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Unsolicited manuscripts submitted to Therapeutic Advances in Neurological Disorders are subject to an Article Processing Charge (APC) of 2650 USD (+VAT where applicable) payable upon acceptance.The article processing charge for Plain Language Summary is 4500 USD. These articles will be published under a Creative Commons licence and will be made openly available.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to neuro@sagepub.co.uk.

Therapeutic Advances in Neurological Disorders delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of neurological conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in neurology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The editors welcome original research articles across all areas of neurology.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a single-blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.

Editor-in-Chief
Professor Ralf Gold, MD Dept of Neurology, Ruhr University Bochum, Bochum, Germany
Deputy Editor
Professor Marinos C Dalakas, MD Thomas Jefferson University, Philadelphia, PA, USA
Associate Editors
Professor Albert Ludolph, MD RKU - Universitäts- und Rehabilitationskliniken, Ulm, Germany
Professor Olaf Stuve, MD, PhD University of Texas Southwestern Medical Center, Dallas, TX, USA
Professor Georgios Tsivgoulis, MD, PhD, MSc, FESO, FEAN, FAAN Second Dept of Neurology, National & Kapodistrian University of Athens, Athens, Greece
Professor Matthew Walker, MA, MB, Bchir, PhD, FRCP University College London, London, UK
Executive Editor
Hemi Malkki, PhD SAGE Publishing, London, UK
Managing Editor
Joshua Gazmin SAGE Publishing, London, UK
Lingling Tian, PhD SAGE Publishing, Shanghai, China
Assistant Editors
Pramila Gawali SAGE Publishing, India
Editorial Board
Praveen Anand, MD Imperial College London, London, UK
Professor Corrado Angelini, MD, PhD University of Padova, Padova, Italy
Professor Melissa Armstrong, MD, MSc, FAAN University of Florida, Gaineswille, FL, USA
Professor Kailash Bhatia, MD University College London, London, UK
Professor Stéphanie Debette, MD, PhD Bordeaux University Hospital, Bordeaux, France
Professor Hans-Christoph Diener, MD, PhD University Essen, Essen, Germany
Professor Peter Goadsby, MBBS, MD, PhD, DSc, FRACP, FRCP King's College, London, UK
Professor Hans-Peter Hartung, MD, PhD, FRCP Heinrich-Heine University, Düsseldorf, Germany
Professor Ryuji Kaji, MD, PhD Tokushima University Graduate School of Medicine, Tokushima, Japan
Professor Michael Kaplitt, MD, PhD Weill Medical College of Cornell University, New York, NY, USA
Professor Trevor Kilpatrick, MBBS PhD FRACP University of Melbourne, Melbourne, Australia
Professor Liping Liu, MD, PhD Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Professor Xavier Montalban, M.D., PhD, FAAN, FEAN, FCAHS Vall d'Hebron University Hospital, Barcelona, Spain
Dr. Ichizo Nishino, MD, PhD National Center of Neurology and Psychiatry, Tokyo, Japan
Professor Michael Platten, MD German Cancer Research Center, Universität Heidelberg, Heidelberg, Germany
Professor Felix Rosenow, MD Universitätsklinikum Frankfurt, Frankfurt am Main, Germany
Dr. Graeme Sills, PhD University of Glasgow, Glasgow, UK
Professor Per Soelberg Sørensen, MD, DMSc, FAAN Copenhagen University Hospital, Copenhagen, Denmark
Professor Maria Pia Sormani, PhD University of Genoa, Genoa, Italy
Professor Turgut Tatlisumak, MD, PhD University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
Professor Klaus V Toyka, MD, FRCP Universität Würzburg, Würzburg, Germany
Professor Eugen Trinka, MD, MSC, FRCP Neuroscience Institute, Christian-Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria
Professor Shuang Wang, MD, PhD Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China Hangzhou, China
Professor Patrick Wen, MD Dana-Farber Cancer Institute, Brigham and Women's Hospital Boston, MA, United States
Professor Jo Wilmshurst, MB BS, MRCPaed, FCPaed, MD Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa
Professor Xuejun Yang, MD, PhD Tianjin Medical University General Hospital, Beijing Tsinghua Changgung Hospital, China
Professor Cuantao Zuo, MD, PhD Fudan University, Shanghai, China
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.